Mounjaro is tirzepatide approved for type 2 diabetes
Among the 4,076 participants, 80% were receiving ACE inhibitors, ARBs, or angiotensin receptor-neprilysin inhibitors, and 15.2% were on SGLT2 inhibitors
However, these two hexapeptides have no similarities with ghrelin in terms of structure, as highlighted by the work of Bowers et al in 2012
This 5-year follow-up to the STAMPEDE clinical trial randomized patients with T2DM to RYGB, VSG or medical management, and showed that RYGB and VSG were superior to medical therapy in terms of weight loss, glycaemic control and reduction in medication use
This gentle introduction prevents potential damage to the delicate peptide structure
Individual medical history, concurrent medications, and treatment goals should guide personalized recommendations regarding dietary choices during semaglutide therapy